Figure 3.
Effects of the clinicopathological variables and risk score on the prognosis of bladder cancer patients. Heat map showing the expression levels of the six immune-related lncRNAs and the distribution of clinicopathological variables between the low-risk and high-risk groups. *, P<0.05; **, P<0.01; ***, P<0.001.